SUBSCRIBE
SUBSCRIBE
News   Business

FORMA Therapeutics, Inc. Teams with TGen Drug Development Services (TD2)

June 18, 2012 | 
1 min read
WATERTOWN, Mass. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--FORMA Therapeutics and TGen Drug Development (TD2) today announced an agreement to jointly develop transformative cancer therapies, leveraging the synergistic capabilities of both organizations.
Alliances
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Entrada Trims 20% of Employees, Focusing on Research Staff
May 2, 2025
 · 
184 min read
 · 
BioSpace Editorial Staff
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Contemporary art collage of hand holding an arrow showing fall. Modern design. Copy space.
Earnings
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Contemporary art collage. Hand put money to golden stack of coins, meaning income from investment. Concept of business strategy, investment, development, market, finance.
Earnings
Lilly’s Revenue Leaps 45% Thanks to Zepbound, Mounjaro, Of Course
May 1, 2025
 · 
1 min read
 · 
Annalee Armstrong